ArticleMolecular therapy. Nucleic acids2026

Targeted FcRn to deliver epitope-optimized RBD confers broad-spectrum mucosal protection against SARS-CoV-2.

Xinlan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.